These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25849006)
1. Limb girdle weakness responding to salbutamol: an Indian family with DOK7 mutation. Khadilkar S; Bhutada A; Nallamilli B; Hegde M Indian Pediatr; 2015 Mar; 52(3):243-4. PubMed ID: 25849006 [TBL] [Abstract][Full Text] [Related]
2. Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation. Lorenzoni PJ; Scola RH; Kay CS; Filla L; Miranda AP; Pinheiro JM; Chaouch A; Lochmüller H; Werneck LC J Neurol Sci; 2013 Aug; 331(1-2):155-7. PubMed ID: 23790237 [TBL] [Abstract][Full Text] [Related]
3. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children. Tsao CY Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645 [TBL] [Abstract][Full Text] [Related]
4. Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations. Burke G; Hiscock A; Klein A; Niks EH; Main M; Manzur AY; Ng J; de Vile C; Muntoni F; Beeson D; Robb S Neuromuscul Disord; 2013 Feb; 23(2):170-5. PubMed ID: 23219351 [TBL] [Abstract][Full Text] [Related]
5. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK. Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479 [TBL] [Abstract][Full Text] [Related]
13. Delineation of molecular characteristics of congenital myasthenic syndromes in Indian families and review of literature. Mishra S; Nair KV; Shukla A Clin Dysmorphol; 2023 Oct; 32(4):162-167. PubMed ID: 37646703 [TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations. Sadeh M; Shen XM; Engel AG Muscle Nerve; 2011 Aug; 44(2):289-91. PubMed ID: 21721016 [TBL] [Abstract][Full Text] [Related]
15. Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic Disorders. Clausen L; Cossins J; Beeson D J Neuromuscul Dis; 2018; 5(2):231-240. PubMed ID: 29865088 [TBL] [Abstract][Full Text] [Related]
16. Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. Müller JS; Herczegfalvi A; Vilchez JJ; Colomer J; Bachinski LL; Mihaylova V; Santos M; Schara U; Deschauer M; Shevell M; Poulin C; Dias A; Soudo A; Hietala M; Aärimaa T; Krahe R; Karcagi V; Huebner A; Beeson D; Abicht A; Lochmüller H Brain; 2007 Jun; 130(Pt 6):1497-506. PubMed ID: 17439981 [TBL] [Abstract][Full Text] [Related]
17. Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia. Webster RG; Vanhaesebrouck AE; Maxwell SE; Cossins JA; Liu W; Ueta R; Yamanashi Y; Beeson DMW Hum Mol Genet; 2020 Aug; 29(14):2325-2336. PubMed ID: 32543656 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis of DOK7 congenital myasthenic syndrome during pregnancy: A case report and literature review. Fernandes M; Caetano A; Pinto M; Medeiros E; Santos L Clin Neurol Neurosurg; 2021 Apr; 203():106591. PubMed ID: 33714798 [TBL] [Abstract][Full Text] [Related]
19. Congenital myasthenia syndrome with demyelinating sensorimotor neuropathy responsive to salbutamol monotherapy: a novel clinical phenotype of CHRNE mutation. Ghosh R; Dubey S; Roy D; Mayo S; Benito-León J Neurol Sci; 2024 Jul; 45(7):3555-3558. PubMed ID: 38411853 [No Abstract] [Full Text] [Related]
20. DOK7 myasthenic syndrome with subacute adult onset during pregnancy and partial response to fluoxetine. Santos M; Cruz S; Peres J; Santos L; Tavares P; Basto JP; Salgado V; Valverde AH Neuromuscul Disord; 2018 Mar; 28(3):278-282. PubMed ID: 29395672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]